Results 211 to 220 of about 24,787 (257)

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. [PDF]

Cells
Hawash M.
europepmc   +1 more source

Crystal structure of (E)-N-(4-bromo-2-(1-(hydroxyimino)ethyl)phenyl)benzamide, C₁₅H₁₃BrN₂O₂

, 2018
Malose J. Mphahlele
openalex   +2 more sources

Palladium-Catalyzed Hydroarylation of <i>N</i>-Propargyl Benzamides: A Direct Route to <i>N</i>-Allylbenzamides and Acid-Induced Cyclization to Oxazolines. [PDF]

J Org Chem
Tanomsiri G, Tummatorn J, Thongsornkleeb C, Ruchirawat S.   +3 more
europepmc   +1 more source

Dramatic expansion of bimodal redox window of indigo by two-electron redox processes. [PDF]

Nat Commun
Roy M, Maji S, Singh V, Dey D, Adhikari D.   +4 more
europepmc   +1 more source

The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors

, 2013
Minhang Xin, Jun Wen, Feng Tang, Chongxing Tu, Han Shen, Xinge Zhao   +5 more
openalex   +1 more source

Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report. [PDF]

Cancer Rep (Hoboken)
Nigi A, Kumasa T, Iwamoto K, Itani H, Kondou S, Uraki J.   +5 more
europepmc   +1 more source

Copper-promoted oxidative mono- and di-bromination of 8-aminoquinoline amides with HBr and DMSO. [PDF]

RSC Adv
Shao C, Liu J, Shen Y, Li L, Ma C, Hu Z, Kan Y, Chen P, Zhang T.   +8 more
europepmc   +1 more source

Key structural requirements of benzamide derivatives for histone deacetylase inhibition: design, synthesis and biological evaluation [PDF]

Narges Cheshmazar, Maryam Hamzeh‐Mivehroud, Salar Hemmati, Hoda Abolhasani, Fatemeh Heidari, Hojjatollah Nozad Charoudeh, Matthes Zessin, Mike Schutkowski, Wolfgang Sippl, Siavoush Dastmalchi   +9 more
openalex   +1 more source

Inhibition of chitin synthesis by 5-benzoylamino-3-phenylisoxazoles with various substituents at two benzene rings and their larvicidal activity. [PDF]

J Pestic Sci
Mori K, Miyashita M, Mori S, Shibata N, Ikeguchi M, Nakagawa Y.   +5 more
europepmc   +1 more source

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring <i>ROS1</i> Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy. [PDF]

Int J Mol Sci
Tang YJ, Chen RH, Lu YS, Wu CE.
europepmc   +1 more source